Drug intelligence / Profile preview

miR-634

Development stage
Preclinical
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

miR-634 is a microRNA that acts as a tumor suppressor by post-transcriptionally regulating multiple oncogenic pathways. In the context of glioblastoma, miR-634 expression is up-regulated by the PPARα activator fenofibrate. It has been shown to directly target the 3'-UTR of CYR61 (Cysteine-rich angiogenic inducer 61), thereby inhibiting cancer cell proliferation. Additionally, miR-634 targets TSC2 (Tuberous Sclerosis Complex 2), a negative regulator of the mTOR signaling pathway, leading to increased phosphorylation of p70 S6 kinase. Beyond glioblastoma, miR-634 has been investigated for its ability to sensitize various cancer cells to chemotherapy by targeting genes involved in mitochondrial homeostasis, anti-apoptosis, and drug efflux. Therapeutic strategies involving miR-634 typically utilize miR-634 mimics to restore its tumor-suppressive function in malignant cells.

Other names
microRNA-634microRNA634microRNA 634
02

Targets

MAPK3 (Mitogen-activated protein kinase 1)TSC2 (Tuberous sclerosis complex 2 protein)CCN1 (Cellular communication network factor 5)AKT (RAC-alpha serine/threonine-protein kinase)Mechanistic target of rapamycin complex 1RPS6KB1 (Ribosomal protein S6 kinase beta-1)

Beyond the preview

Go deeper on miR-634.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-634.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call